List of required information for application:
1. Investigational agent: Provide details about the drug, biologic, surgical therapy, or device that will be used in the clinical trial.
2. Justification for future trial: Explain how the proposed trial will contribute to the justification for designing a future trial. Outline the potential benefits and impact of the trial on future research.
3. Biomarker validation studies: Describe how the trial will contribute to biomarker validation studies. Explain the importance of biomarkers in the context of the proposed study and how their validation will improve clinical practice or understanding of the disease.
4. Proof of mechanism clinical studies: Explain how the trial will provide proof of mechanism for the investigational agent. Describe the specific mechanism being targeted and how the trial will demonstrate its efficacy or mechanism of action.
5. Disease selection: Justify the choice of disease for the study based on the NINDS' strategic plan and clinical research interests. Provide a clear rationale for why studying this disease is important and how it aligns with the goals of NINDS.
6. Access to NeuroNEXT infrastructure: Describe how the applicant plans to utilize and benefit from the NeuroNEXT infrastructure. Explain the specific resources and support required from the NeuroNEXT Clinical Coordinating Center, Data Coordinating Center, and clinical sites.
7. Implementation plan: Outline the proposed study's implementation plan and how it will be efficiently executed with the assistance of the NeuroNEXT infrastructure. Provide details about the timeline, recruitment/retention strategies, and on-site implementation of the clinical protocol.
8. Existing NeuroNEXT infrastructure: Indicate whether the applicant is already part of the NeuroNEXT infrastructure. If not, explain how the applicant plans to collaborate effectively with the existing infrastructure to ensure seamless integration and maximize the benefits of the support provided.
9. Statistical and data management support: Describe the specific statistical and data management support required from the NeuroNEXT Data Coordinating Center. Explain how the data management plan will be developed and implemented to ensure the accuracy and integrity of the trial data.
10. Clinical protocol: Provide a detailed description of the proposed clinical protocol, including the study design, inclusion/exclusion criteria, endpoints, and assessment measures. Explain how the protocol aligns with the objectives of the trial and will provide the necessary data for future trial design or biomarker validation.
11. Other required application components: Include any additional information or documents requested in the application guidelines, such as budget, biosketches, and letters of support
